-
bioBoaVista manufactures customised media for COVID nasal diagnostic tests using the Flexicon PF7
bioBoaVista, a Brazilian specialist culture media manufacturer for microbiological diagnosis, has developed a viral transport medium (MTV) for more efficient nasal tests for the diagnosis of COVID-19. The novel medium stabilises samples for significantly longer; up to 48 hours at room temperature and up to 5 days between 2°C to 8°C, compared to standard saline…
-
Watson-Marlow pumps now feature EtherNet/IP™ control
Industry 4.0 connectivity offers fast and easy access to pump data with EtherNet/IP. Enhanced network control allows pump users to improve process performance and reduce operating costs Gateway connectivity to third-party pressure and flow sensors Falmouth, UK, 16th June 2020 / Sciad Newswire / The industry-leading range of 530, 630 and 730 peristaltic pumps from Watson-Marlow Fluid Technology…
-
Don’t let lockdown delay your HPV screening test
As the Covid-19 pandemic continues to cause disruption across the country, it is likely that you will have seen delays and cancellations to your usual GP and outpatient appointments. With no clear end in sight, it may be some time before NHS services are able to return to normal. One area that has been particularly…
-
The RSA Group reveals new global brand
London, UK, 5th June 2020 / Sciad Newswire / The RSA Group, the leading global specialist in Life Sciences Executive Search, is excited to share its new global brand and website. The RSA Group connects elite life science talent with extraordinary organisations pioneering medical advances, developing new treatments to ease or cure debilitating diseases. Its new brand will reflect…
-
Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman
Cambridge, UK, 2nd June 2020 / Sciad Newswire / Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd. Eddy began his research career at the University of Leeds obtaining his PhD in virology. After postdoctoral research at McMaster University in Canada, he joined the Paterson Institute for Cancer Research in Manchester….
-
UCB and N-SIDE increase their strategic collaboration
Louvain-la-Neuve, Belgium, 2nd June 2020 / Sciad Newswire / N-SIDE, provider of innovative software and strategic consulting services, announced that UCB has signed a 3-year agreement increasing their collaboration in clinical supply optimization. With this new agreement, UCB will use the N-SIDE Suite for Clinical Trials solution and N-SIDE consulting services to optimize the supply management from protocol…
-
MindSpire wins Innovate UK award to explore early biomarkers of Coronavirus infection
London, UK, 28th May 2020 / Sciad Newswire / MindSpire, an innovative start up focused on decoding and treating chronic stress, has been awarded a grant from the UK’s innovation agency, Innovate UK’s “Business-led Innovation in Response to Global Disruption” funding call, which received over 8,500 applications. Coronavirus spreads successfully across communities partly because symptoms often appear several days after…
-
Government supports small labs to help ramp up COVID-19 testing for frontline health and care workers
Oxford, UK, 15th May 2020 / Sciad Newswire / The Department of Health and Social Care has agreed a multi-million pound contract with the Covid-19 Testing Network to fund tens of thousands of Covid-19 antigen tests for health and care workers across the country. The government’s support will make it easier for small labs to convert to Covid-19 testing, allowing capacity to rapidly…
-
Covid-19 Volunteer Testing Network scaling up – delivering tests for GPs and care home workers
The Covid-19 Volunteer Testing Network is scaling up towards thousands of tests per day 6 labs around the country are now live with 20 more in the pipeline Local labs can deliver a fast-turnaround for their nearby GPs and care home workers One lab in the network identified an outbreak in a community care provider…
-
Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology
Unique transdermal delivery technology and medicines for rare diseases combine to deliver significant quality-of-life benefits for patients Cambridge & Coventry, UK, 5th May 2020 / Sciad Newswire / Cycle Pharmaceuticals Ltd (Cycle) and Medherant Ltd (Medherant) are pleased to announce that they have signed an agreement to develop and commercialize multiple products using the TEPI Patch® technology. Cycle will utilise…